Document 6577112
Transcription
Document 6577112
ISR AUTUMN 2014 MEETING held on Thursday 11th & Friday 12th September (Fitzpatrick Castle Hotel, Killiney - Co.Dublin) AWARD PRESENTED TO Dr Lorna Gallagher: Young Adelaide & Meath Investigator Hospital, Tallaght ABSTRACT TITLE ABSTRACT NO./REF 14A160 Pseudostarvation by AMPK activator therapy is associated with reduced disease activity and downregulation of pro-inflammatory responses in Rheumatoid Arthritis (RA) Abstract 4 (14A156) MTX inhibits maigrational and invasive mechanisms in Rheumatoid Arthritis Ist Oral Sian Cregan: School of Medicine & Medical Science, UCD 2nd Oral Dr S A Ramakrishnan: Our Lady's Hospital, Navan Abstract 7 (14A111) Outcome of Treat of Target (T2T) in newly diagnosed Rheumatoid Arthritis (RA) at Rheumatology Department, Our Lady's Hospital, Navan 1st Poster Bernie McGowan: Our Lady's Hospital, Manorhamilton Abstract 14 (14A103) Adherence and persistence to urate-lowering therapies in the Irish setting 2nd Poster Dr Lorraine O'Neill: Dublin Academic Medical Centre, SVUH Abstract 63 (14A183) Altered miRNA expression in Giant Cell Arteritis Case Oral Dr F A Ashraf: University Hospital Limerick 14A177 Budd-Chiari syndrome in a patient with intestinal Behcet’s disease: Two recognized complications with serious and devastating outcome that should not be missed
Similar documents
Global Rheumatoid Arthritis Diagnosis Test market is expected to be valued at US$ 738.7 Mn by the end of 2022
Global rheumatoid arthritis diagnosis tests market has been estimated to be valued at US$ 485.5 Mn in 2015, and is anticipated to increase to US$ 738.7 Mn by 2022, registering a CAGR of 6.2% during the forecast period. Incidence of RA are increasing among children in Europe and North America. This increased incidence rate calls for adoption of minimally-invasive test methods to diagnose rheumatoid arthritis. Hence, there is high demand for RA test kits with minimally-invasive testing method in Europe and North America.
More information